CRISPR Therapeutics AG
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRIS…
Biotechnology
CH, Zug [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
CRISPR Therapeutics AG can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCRISPR Therapeutics AG can't present revenue by segment